Tramadol Reduces the Sweating, Vasoconstriction, and Shivering Thresholds

The analgesic tramadol inhibits the neuronal reuptake of norepinephrine and 5-hydroxytryptamine, facilitates 5-hydroxytryptamine release, and activates [micro sign]-opioid receptors. Each of these actions is likely to influence thermoregulatory control. We therefore tested the hypothesis that tramadol inhibits thermoregulatory control. Eight volunteers were evaluated on four study days, on which they received no drugs, tramadol 125 mg, tramadol 250 mg, and tramadol 250 mg with naloxone, respectively. Skin and core temperatures were gradually increased until sweating was observed and then decreased until vasoconstriction and shivering were detected. The core temperature triggering each response defined its threshold. Tramadol decreased the sweating threshold by -1.03 +/- 0.67[degree sign]C[center dot][micro sign]g-1[center dot]mL (r (2) = 0.90 +/- 0.12). Tramadol also decreased the vasoconstriction threshold by -3.0 +/- 4.0[degree sign]C[center dot][micro sign]g-1[center dot]mL (r2 = 0.94 +/- 0.98) and the shivering threshold by -4.2 +/- 4.0[degree sign]C[center dot][micro sign]g-1[center dot]mL (r2 = 0.98 +/- 0.98). The sweating to vasoconstriction interthreshold range nearly doubled from 0.3 +/- 0.4[degree sign]C to 0.7 +/- 0.6[degree sign]C during the administration of large-dose tramadol (P = 0.04). The addition of naloxone only partially reversed the thermoregulatory effects of tramadol. The thermoregulatory effects of tramadol thus most resemble those of midazolam, another drug that slightly decreases the thresholds triggering all three major autonomic thermoregulatory defenses. In this respect, both drugs reduce the "setpoint" rather than produce a generalized impairment of thermoregulatory control. Nonetheless, tramadol nearly doubled the interthreshold range at a concentration near 200 ng/mL. This indicates that tramadol slightly decreases the precision of thermoregulatory control in addition to reducing the setpoint. Implications: The authors evaluated the effects of the analgesic tramadol on the three major thermoregulatory responses: sweating, vasoconstriction, and shivering. Tramadol had only slight thermoregulatory effects. Its use is thus unlikely to provoke hypothermia or to facilitate fever. (Anesth Analg 1998;87:173-9)

[1]  P. Talke,et al.  Dexmedetomidine Does Not Alter the Sweating Threshold, But Comparably and Linearly Decreases the Vasoconstriction and Shivering Thresholds , 1997, Anesthesiology.

[2]  D. Sessler,et al.  Mild perioperative hypothermia. , 1997, The New England journal of medicine.

[3]  A. Bjorksten,et al.  Meperidine Decreases the Shivering Threshold Twice as Much as the Vasoconstriction Threshold , 1997, Anesthesiology.

[4]  J. Witte,et al.  Tramadol in the treatment of postanesthetic shivering , 1997, Acta anaesthesiologica Scandinavica.

[5]  D. Sessler,et al.  Clonidine Increases the Sweating Threshold, but Does Not Reduce the Gain of Sweating , 1996, Anesthesia and analgesia.

[6]  D. Sessler,et al.  Sympathetic Nervous System Does Not Mediate Reflex Pupillary Dilation during Desflurane Anesthesia , 1996, Anesthesiology.

[7]  D. Sessler,et al.  Desflurane Slightly Increases the Sweating Threshold but Produces Marked, Nonlinear Decreases in the Vasoconstriction and Shivering Thresholds , 1995, Anesthesiology.

[8]  A. Bjorksten,et al.  Alfentanil Slightly Increases the Sweating Threshold and Markedly Reduces the Vasoconstriction and Shivering Thresholds , 1995, Anesthesiology.

[9]  A. Bjorksten,et al.  Midazolam Minimally Impairs Thermoregulatory Control , 1995, Anesthesia and analgesia.

[10]  A. Bjorksten,et al.  Propofol Linearly Reduces the Vasoconstriction and Shivering Thresholds , 1995, Anesthesiology.

[11]  Hank Lin,et al.  Increasing Mean Skin Temperature Linearly Reduces the Core‐ temperature Thresholds for Vasoconstriction and Shivering in Humans , 1995, Anesthesiology.

[12]  M. Ozaki,et al.  Heat Flow and Distribution during Induction of General Anesthesia , 1994, Anesthesiology.

[13]  Makoto Ozaki,et al.  Rate and Gender Dependence of the Sweating, Vasoconstriction, and Shivering Thresholds in Humans , 1994, Anesthesiology.

[14]  D. Sessler,et al.  Naloxone, Meperidine, and Shivering , 1993, Anesthesiology.

[15]  L. Beydon,et al.  Clonidine Comparably Decreases the Thermoregulatory Thresholds for Vasoconstriction and Shivering in Humans , 1993, Anesthesiology.

[16]  M. Lamy,et al.  Clonidine and Ketanserin Both Are Effective Treatment for Postanesthetic Shivering , 1993, Anesthesiology.

[17]  D. McTavish,et al.  Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. , 1993, Drugs.

[18]  D. Sessler,et al.  The Effects of Preinduction Warming on Temperature and Blood Pressure during Propofol/Nitrous Oxide Anesthesia , 1993, Anesthesiology.

[19]  D. Nierenberg,et al.  The central nervous system serotonin syndrome , 1993, Clinical pharmacology and therapeutics.

[20]  C. Blatteis,et al.  Preoptic norepinephrine-induced hypothermia is mediated by alpha 2-adrenoceptors. , 1992, The American journal of physiology.

[21]  B. Driessen,et al.  Interaction of the central analgesic, tramadol, with the uptake and release of 5‐hydroxytryptamine in the rat brain in vitro , 1992, British journal of pharmacology.

[22]  L. Casteilla,et al.  Molecular studies of the uncoupling protein , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  D. Sessler,et al.  Skin-surface temperature gradients correlate with fingertip blood flow in humans. , 1990, Anesthesiology.

[24]  K. Lehmann,et al.  Postoperative Patient‐Controlled Analgesia with Tramadol: Analgesic Efficacy and Minimum Effective Concentrations , 1990 .

[25]  C B Wenger,et al.  Regulation of the cutaneous circulation. , 1986, Federation proceedings.

[26]  H. Barth,et al.  Bioavailability of enteral tramadol formulations. 1st communication: capsules. , 1986, Arzneimittel-Forschung.

[27]  W R Martin,et al.  Pharmacology of opioids. , 1983, Pharmacological reviews.

[28]  F. Mora,et al.  Involvement of α- and β-adrenoreceptors in the central action of norepinephrine on temperature, metabolism, heart and respiratory rates of the conscious primate , 1983, Brain Research Bulletin.

[29]  M. Frydman,et al.  Nonshivering thermogenesis in the rat. II. Measurements of blood flow with microspheres point to brown adipose tissue as the dominant site of the calorigenesis induced by noradrenaline. , 1978, Canadian journal of physiology and pharmacology.

[30]  E R Nadel,et al.  Sensitivity to central and peripheral thermal stimulation in man. , 1970, Journal of applied physiology.

[31]  W. Weyland,et al.  [Perioperative hypothermia]. , 1998, Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS.

[32]  R. Shank,et al.  Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. , 1992, The Journal of pharmacology and experimental therapeutics.

[33]  P. Lomax,et al.  Body temperature : regulation, drug effects, and therapeutic implications , 1979 .